Collections: Health Policy and Services Research / Copyright: Public domain / Recently Added: Within 6 Months - Digital Collections - National Library of Medicine Search Results

Start Over Collections Health Policy and Services Research ✖ Copyright Public domain ✖ Recently Added Within 6 Months ✖

21. CBO’s analysis of the long-term budgetary outlook: presentation at the University of Michigan’s 71st Annual Economic Outlook Conference

Author(s):: Dahl, Molly W., author
Publication:: [Washington, D.C.] : Congressional Budget Office, November 16, 2023
Subject(s):: Budgets -- trends
Federal Government
Forecasting
Health Care Costs -- trends
United States

22. CBO’s role and most recent long-term budget projections: presentation at a meeting of the National Conference of State Legislatures' budget working group

Author(s):: Dahl, Molly W., author
Publication:: [Washington, D.C.] : Congressional Budget Office, December 6, 2023
Subject(s):: Budgets -- trends
Federal Government
United States
United States. Congressional Budget Office.

23. CDC found ways to use data to understand and address COVID-19 health disparities, despite challenges with existing data

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2022
Subject(s):: COVID-19
Data Analysis
Healthcare Disparities
Public Reporting of Healthcare Data
United States
Centers for Disease Control and Prevention (U.S.)

24. CDC has improved the nursing home reporting process for COVID-19 Data in NHSN, but challenges remain

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2024
Subject(s):: COVID-19
Data Collection
Government Regulation
Mandatory Reporting
Nursing Homes
United States
Centers for Disease Control (U.S.)

25. CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):: COVID-19 Testing -- instrumentation
Government Programs
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

26. CDC’S Vaccines for Children program recipients did not conduct site visits at some providers as required

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):: Child Health
Government Programs
Government Regulation
Immunization Programs
Vaccines -- supply & distribution
United States
Centers for Disease Control and Prevention (U.S.)
Vaccines for Children (Program)

27. CDC’s internal control weaknesses led to its initial COVID-19 test kit failure, but CDC ultimately created a working test kit

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):: COVID-19 Testing -- instrumentation
Equipment Failure Analysis
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

28. CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):: Child Abuse -- legislation & jurisprudence
Elder Abuse -- legislation & jurisprudence
Government Regulation
Medicare -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

29. CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):: Government Regulation
Managed Care Programs -- organization & administration
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

30. CMS should bolster its oversight of manufacturer-submitted average sales price data to ensure accurate Part B drug payments

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
Subject(s):: Cost Control
Drug Costs
Drug Industry
Government Regulation
Medicare Part B
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

« Previous
Next »
1
2
3
4
5
6
7
…
21
22